Treatment approaches for patients with sustained VT/VF.
Mitchell
L B
LB
Calgary Regional Health Authority, University of Calgary, Alberta.
Roy
D
D
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D017115:Catheter Ablation; D016757:Death, Sudden, Cardiac / Q000517:prevention & control; D003657:Decision Making; D017147:Defibrillators, Implantable; D006801:Humans; D009204:Myocardial Revascularization; D017180:Tachycardia, Ventricular / Q000628:therapy*; D014693:Ventricular Fibrillation / Q000628:therapy*
D000889:Anti-Arrhythmia Agents